Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Missouri Medical Cannabis Market by Product (Buds, Oils, Tinctures) and by Application (Chronic Pain, Mental Disorders, Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11190

Pages: NA

Charts: NA

Tables: NA

Missouri Medical Cannabis Market Outlook:

The Missouri medical cannabis market is experiencing a major growth, and will grow considerably in next few years.  Cannabis, also known as marijuana is a psychoactive drug that is produced from the Cannabis plant used primarily for medical or recreational purposes. Medical use of cannabis was legalized in Missouri in 2018 and the commercialization is expected to begin from 2020. Medical cannabis has attained varied acceptance in the medical community as a legitimate course of treatment for illnesses such as childhood seizures, glaucoma, bipolar disorder, Posttraumatic stress disorder (PTSD), schizophrenia, weight loss during chemotherapy, and many others. Cannabis is still federally prohibited as a Schedule drug, and while it is unclear how the current administration will address recreational use.

COVID-19 scenario analysis:

  • COVID-19 has affected the medical cannabis market.  For instance, COVID-19 has delayed medical and recreational cannabis launches and licensing rounds around the U.S. in the short term as state and local jurisdictions scramble to complete the tasks and paperwork necessary for marijuana programs to move forward.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Increase in research about the benefits of marijuana on human health, rise in awareness among patients about their benefits, and surge in prevalence of chronic diseases are major factors driving the growth of market in Missouri (U.S.) state. However, since marijuana has still not been legalized for recreational use in the state can hinder the growth of the market. In addition, from November 2018, cultivation, processing, manufacturing, and distribution for the medical application have been legalized in Missouri. This is expected to provide lucrative opportunity to the medical cannabis market in near future.

The Missouri medical cannabis market trends are as follows:

New product launches to flourish the market

The first launch of Missouri medical cannabis. For instance, In June 2020, St. Louis-based BeLeaf Medical became the first medical cannabis cultivator in Missouri to launch operations and as a vertically integrated company with 10 total licenses in the state, President Kevin Riggs says there is much more to come.

Surge in usage in healthcare applications

The cannabis are in increasing demand to treat patients  such as epilepsy, post-traumatic stress disorder (PTSD), autism, chronic pain, or muscle spasms due to multiple sclerosis, Parkinson’s disease, and seizures. For instance, as of December 2019, a total of 2,200 pre-filed application forms have been received by DHSS and more than 22,000 Missourians have applied and been granted a qualifying patient ID card.

Key benefits of the report:

  • This study presents the analytical depiction of the Missouri medical cannabis industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Missouri Medical Cannabis market share.
  • The current market is quantitatively analyzed to highlight the Missouri Medical Cannabis market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Missouri Medical Cannabis market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Missouri Medical Cannabis Market research report:

  • What are the leading market players active in the Missouri Medical Cannabis market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Key Market Segments

  • By Product
    • Buds
    • Oils
    • Tinctures
  • By Application
    • Chronic Pain
    • Mental Disorders
    • Cancer
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Aurora marijuana Inc.
  • OrganiGram Holding Inc.
  • Terra Tech Corp.
  • VIVO Cannabis Inc.
  • Cronos Group Inc
  • Medical Marijuana, Inc
  • Tilray, Inc
  • Canopy Growth Corporation
  • Maricann Group, Inc

 
Other Players

  • OrganiGram Holding Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MISSOURI MEDICAL CANNABIS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Buds

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Oils

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Tinctures

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: MISSOURI MEDICAL CANNABIS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Chronic Pain

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Mental Disorders

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cancer

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MISSOURI MEDICAL CANNABIS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Missouri Medical Cannabis Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Missouri Medical Cannabis Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Missouri Medical Cannabis Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Missouri Medical Cannabis Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Missouri Medical Cannabis Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Missouri Medical Cannabis Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Missouri Medical Cannabis Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Missouri Medical Cannabis Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Missouri Medical Cannabis Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Missouri Medical Cannabis Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Missouri Medical Cannabis Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Missouri Medical Cannabis Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Missouri Medical Cannabis Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Missouri Medical Cannabis Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Missouri Medical Cannabis Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Missouri Medical Cannabis Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Missouri Medical Cannabis Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Missouri Medical Cannabis Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Missouri Medical Cannabis Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Missouri Medical Cannabis Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Missouri Medical Cannabis Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Missouri Medical Cannabis Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Missouri Medical Cannabis Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Missouri Medical Cannabis Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Missouri Medical Cannabis Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. VIVO Cannabis Inc.

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Tilray, Inc

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Medical Marijuana, Inc

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. OrganiGram Holding Inc.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Aurora Marijuana Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Canopy Growth Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Cronos Group Inc

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Maricann Group, Inc

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Terra Tech Corp.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MISSOURI MEDICAL CANNABIS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR BUDS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR OILS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR TINCTURES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MISSOURI MEDICAL CANNABIS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR CANCER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MISSOURI MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MISSOURI MEDICAL CANNABIS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA MISSOURI MEDICAL CANNABIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 14. U.S. MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. U.S. MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. CANADA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. CANADA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE MISSOURI MEDICAL CANNABIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. ITALY MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. ITALY MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. UK MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. UK MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC MISSOURI MEDICAL CANNABIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. CHINA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. CHINA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. INDIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. INDIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA MISSOURI MEDICAL CANNABIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. UAE MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. UAE MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA MISSOURI MEDICAL CANNABIS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA MISSOURI MEDICAL CANNABIS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. VIVO CANNABIS INC.: KEY EXECUTIVES
  • TABLE 74. VIVO CANNABIS INC.: COMPANY SNAPSHOT
  • TABLE 75. VIVO CANNABIS INC.: OPERATING SEGMENTS
  • TABLE 76. VIVO CANNABIS INC.: PRODUCT PORTFOLIO
  • TABLE 77. VIVO CANNABIS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. TILRAY, INC: KEY EXECUTIVES
  • TABLE 79. TILRAY, INC: COMPANY SNAPSHOT
  • TABLE 80. TILRAY, INC: OPERATING SEGMENTS
  • TABLE 81. TILRAY, INC: PRODUCT PORTFOLIO
  • TABLE 82. TILRAY, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. MEDICAL MARIJUANA, INC: KEY EXECUTIVES
  • TABLE 84. MEDICAL MARIJUANA, INC: COMPANY SNAPSHOT
  • TABLE 85. MEDICAL MARIJUANA, INC: OPERATING SEGMENTS
  • TABLE 86. MEDICAL MARIJUANA, INC: PRODUCT PORTFOLIO
  • TABLE 87. MEDICAL MARIJUANA, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. ORGANIGRAM HOLDING INC.: KEY EXECUTIVES
  • TABLE 89. ORGANIGRAM HOLDING INC.: COMPANY SNAPSHOT
  • TABLE 90. ORGANIGRAM HOLDING INC.: OPERATING SEGMENTS
  • TABLE 91. ORGANIGRAM HOLDING INC.: PRODUCT PORTFOLIO
  • TABLE 92. ORGANIGRAM HOLDING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. AURORA MARIJUANA INC.: KEY EXECUTIVES
  • TABLE 94. AURORA MARIJUANA INC.: COMPANY SNAPSHOT
  • TABLE 95. AURORA MARIJUANA INC.: OPERATING SEGMENTS
  • TABLE 96. AURORA MARIJUANA INC.: PRODUCT PORTFOLIO
  • TABLE 97. AURORA MARIJUANA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. CANOPY GROWTH CORPORATION: KEY EXECUTIVES
  • TABLE 99. CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
  • TABLE 100. CANOPY GROWTH CORPORATION: OPERATING SEGMENTS
  • TABLE 101. CANOPY GROWTH CORPORATION: PRODUCT PORTFOLIO
  • TABLE 102. CANOPY GROWTH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. CRONOS GROUP INC: KEY EXECUTIVES
  • TABLE 104. CRONOS GROUP INC: COMPANY SNAPSHOT
  • TABLE 105. CRONOS GROUP INC: OPERATING SEGMENTS
  • TABLE 106. CRONOS GROUP INC: PRODUCT PORTFOLIO
  • TABLE 107. CRONOS GROUP INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. MARICANN GROUP, INC: KEY EXECUTIVES
  • TABLE 109. MARICANN GROUP, INC: COMPANY SNAPSHOT
  • TABLE 110. MARICANN GROUP, INC: OPERATING SEGMENTS
  • TABLE 111. MARICANN GROUP, INC: PRODUCT PORTFOLIO
  • TABLE 112. MARICANN GROUP, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. TERRA TECH CORP.: KEY EXECUTIVES
  • TABLE 114. TERRA TECH CORP.: COMPANY SNAPSHOT
  • TABLE 115. TERRA TECH CORP.: OPERATING SEGMENTS
  • TABLE 116. TERRA TECH CORP.: PRODUCT PORTFOLIO
  • TABLE 117. TERRA TECH CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MISSOURI MEDICAL CANNABIS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MISSOURI MEDICAL CANNABIS MARKET
  • FIGURE 3. SEGMENTATION MISSOURI MEDICAL CANNABIS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MISSOURI MEDICAL CANNABIS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMISSOURI MEDICAL CANNABIS MARKET
  • FIGURE 11. MISSOURI MEDICAL CANNABIS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. MISSOURI MEDICAL CANNABIS MARKET FOR BUDS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MISSOURI MEDICAL CANNABIS MARKET FOR OILS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MISSOURI MEDICAL CANNABIS MARKET FOR TINCTURES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MISSOURI MEDICAL CANNABIS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. MISSOURI MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MISSOURI MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MISSOURI MEDICAL CANNABIS MARKET FOR CANCER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MISSOURI MEDICAL CANNABIS MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: MISSOURI MEDICAL CANNABIS MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. VIVO CANNABIS INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. VIVO CANNABIS INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. VIVO CANNABIS INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. TILRAY, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. TILRAY, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. TILRAY, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. MEDICAL MARIJUANA, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. MEDICAL MARIJUANA, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. MEDICAL MARIJUANA, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. ORGANIGRAM HOLDING INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. ORGANIGRAM HOLDING INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. ORGANIGRAM HOLDING INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. AURORA MARIJUANA INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. AURORA MARIJUANA INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. AURORA MARIJUANA INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. CANOPY GROWTH CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. CANOPY GROWTH CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. CANOPY GROWTH CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. CRONOS GROUP INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. CRONOS GROUP INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. CRONOS GROUP INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. MARICANN GROUP, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. MARICANN GROUP, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. MARICANN GROUP, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. TERRA TECH CORP.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. TERRA TECH CORP.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. TERRA TECH CORP.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Missouri Medical Cannabis Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved